Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant - MassDevice
Regulatory Submission Template
EnteroMedics VBLOC Obesity Device Fails (NASDAQ:RSLS) | Seeking Alpha
MC2402 Maestro Rechargeable System Mobile Charger Test Report NC1405671.1 FCC 15.209 Enteromedics, .
Latest weight loss surgery finds slim support from insurers
Maestro Rechargeable System | The Implantable Appetite "Pacemaker"
Newly Approved Weight Loss Device Blocks the Vagus Nerve
The Maestro Rechargeable System- EnteroMedics
Roseville St. Paul firm gets FDA approval for weight-loss device
EnteroMedics – The World of Implantable Devices
FDA Approves Weight Loss Device that Uses Electronic Waves | Interference Technology
Weight Loss from Maestro Rechargeable System and Cost, Side Effects, Efficacy, Warnings, and Instructions | Jared Yoshizumi, PharmD | RxEconsult
FDA approves vagal blocking device for obesity | CHEST Physician
Unique ways to lose weight get FDA nods
Amendment No. 7 to Form S-1
EnteroMedics, Inc., St. Paul | Twin Cities Business
New ENTEROMEDICS Neuroregulator Rechargeable Neuroregulator Neurology General For Sale - DOTmed Listing #3394210:
Health Management and Leadership Portal | Implantable neurostimulator / for vagus nerve stimulation Maestro® EnteroMedics | HealthManagement.org
FDA approves implant designed to treat obesity by zapping nerves | CTV News
The Maestro Rechargeable System - New Weight-Loss Surgical Product Approved By FDA - Clinique Michel Gagner
Implantable neurostimulator - vBloc® Maestro® - EnteroMedics - for vagus nerve stimulation
FDA approves Maestro Rechargeable System for severely obese patients | Daily Mail Online
Newly Approved Weight Loss Device Blocks the Vagus Nerve
Weighing the risk of new, FDA-approved obesity fighter | wfaa.com
